Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag in Preoperative Immune Thrombocytopenia
NCT06562738Phase 4Recruiting
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Jun 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hetrombopag in immune thrombocytopenia (ITP), sponsored by Third People's Hospital of Chengdu. Started Jun 2024; status: recruiting.
02
Drugs
hetrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT06562738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06562738.